Reuters logo
BRIEF-Hainan Shuangcheng Pharmaceuticals revises Q1-Q3 2016 net loss outlook to be 210-230 mln yuan
October 18, 2016 / 8:26 AM / in a year

BRIEF-Hainan Shuangcheng Pharmaceuticals revises Q1-Q3 2016 net loss outlook to be 210-230 mln yuan

Oct 18 (Reuters) - Hainan Shuangcheng Pharmaceuticals Co Ltd :

* Sees net loss for Q1-Q3 2016 to be 210 million yuan to 230 million yuan, compared to net profit of the same period in 2015 (37.3 million yuan)

* In the previous outlook, the company expected the net loss for Q1-Q3 2016 to be 28 million yuan to 32 million yuan

* Comments that the recording of impairment loss of investment is the main reason for the outlook

Source text in Chinese: goo.gl/5eoaMm

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below